Sosei Heptares has entered into a multi-target research collaboration and licence agreement with Genentech to discover and develop medicines that modulate G protein-coupled receptors (GPCRs), membrane proteins that are involved in a broad range of biological processes and diseases. GCPRs play a central role in cellular physiology including the regulation of the immune and nervous systems and the growth and metastasis of some types of tumours.
